APA (7th ed.) Citation

Nasonov, E. L., Avdeeva, A. S., & Popkova, T. V. (2021). New possibilities of pharmacotherapy for systemic lupus erythematosus: Prospects for the use of anifrolumab (monoclonal antibodies to type I interferon receptor). IMA PRESS LLC.

Chicago Style (17th ed.) Citation

Nasonov, E. L., A. S. Avdeeva, and T. V. Popkova. New Possibilities of Pharmacotherapy for Systemic Lupus Erythematosus: Prospects for the Use of Anifrolumab (monoclonal Antibodies to Type I Interferon Receptor). IMA PRESS LLC, 2021.

MLA (9th ed.) Citation

Nasonov, E. L., et al. New Possibilities of Pharmacotherapy for Systemic Lupus Erythematosus: Prospects for the Use of Anifrolumab (monoclonal Antibodies to Type I Interferon Receptor). IMA PRESS LLC, 2021.